Prescriptions for drugs that are exempt from utilization review increased in the first half of 2018 following the formulary launch, the California Workers’ Compensation Institute reported Wednesday.
The Division of Workers’ Compensation in late 2017 adopted formulary rules that designate some drugs as “exempt” from prospective utilization review when used in accordance recommendations in the Medical Treatment Utilization Schedule. Drugs designated “non-exempt,” as well as those that aren’t listed in the MTUS drug list, remained subject to prospective ...
Comments